Search

Your search keyword '"Ede, R"' showing total 120 results

Search Constraints

Start Over You searched for: Author "Ede, R" Remove constraint Author: "Ede, R"
120 results on '"Ede, R"'

Search Results

1. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

7. The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis

16. Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide

27. Myocarditis and fulminant hepatic failure from coxsackievirus B infection.

28. Frequency of pancreatitis in fulminant hepatic failure using isoenzyme markers.

29. Ultrasound scanning and 99mTc sulphur colloid scintigraphy in diagnosis of Budd-Chiari syndrome.

30. Wilson's disease: clinical presentation and use of prognostic index.

31. Budd-Chiari syndrome presenting as fulminant hepatic failure.

32. Physico-chemical and sensory properties of formulated syrup from black plum (Vitex doniana) fruit.

34. Clearance of refractory bile duct stones with extracorporeal shockwave lithotripsy.

36. A case of trisomy of chromosome 15.

38. An evaluation of telepsychiatry during the COVID-19 pandemic across service users, carers and clinicians : an international mixed methods study

43. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

44. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

45. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

46. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

47. Psilocybin for depression.

48. Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey.

49. Assessing the Impact of Evidence-Based Mental Health Guidance During the COVID-19 Pandemic: Systematic Review and Qualitative Evaluation.

50. Count Me In: an inclusive approach towards patient recruitment for clinical research studies in the NHS.

Catalog

Books, media, physical & digital resources